Stay updated on Itolizumab in Lupus Nephritis Clinical Trial
Sign up to get notified when there's something new on the Itolizumab in Lupus Nephritis Clinical Trial page.

Latest updates to the Itolizumab in Lupus Nephritis Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA new page revision (v3.6.3) was added to the Study Record History and the previous revision (v3.6.2) was removed, reflecting a small update to the page's revision history.SummaryDifference0.1%

- Check24 days agoChange DetectedAdded a new revision entry (v3.6.2) to the study's record history and removed the previous entry (v3.6.0). This indicates a minor page release update rather than a change to study content.SummaryDifference0.1%

- Check38 days agoChange DetectedA note shows recruitment is closed (no longer looking for participants). The record version has been updated to v3.6.0, replacing the prior v3.5.5.SummaryDifference0.4%

- Check45 days agoChange DetectedBiocon Limited is listed as sponsor/collaborator in the study record, replacing Equillium. The record shows a new revision (v3.5.5) dated 2026-06-04, indicating an update to the sponsor/identification information.SummaryDifference0.8%

- Check66 days agoChange DetectedThe Record History page shows a new revision label (v3.5.4) replacing the previous v3.5.3, indicating an updated release of the page’s revision history information.SummaryDifference0.1%

- Check81 days agoChange DetectedThe history now includes a newer Revision: v3.5.3. The older Revision: v3.5.2 is removed from the history view.SummaryDifference0.1%

Stay in the know with updates to Itolizumab in Lupus Nephritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Itolizumab in Lupus Nephritis Clinical Trial page.